Evidence map›Paper›PMID 36271817›Full record

Observational studyAmerican journal of medical genetics. Part A2023

A multicenter study to evaluate pain characteristics in osteogenesis imperfecta.

Mercedes Rodriguez Celin, Karen M Kruger, Angela Caudill, Chaya N Murali, Sandesh C S Nagamani, Members of the Brittle Bone Disorders Consortium (BBDC), Peter A Smith, Gerald F Harris

Open access · greenAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in American journal of medical genetics. Part A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Osteogenesis imperfecta and the family: A qualitative analysis of the experiences of family and caregivers.Families, systems & health : the journal of collaborative family healthcare · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mercedes Rodriguez CelinOrthopaedic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.ORCID https://orcid.org/0000-0001-5750-7222
Karen M KrugerMotion Analysis Laboratory, Shriners Hospitals for Children, Chicago, Illinois, USA.
Angela CaudillMotion Analysis Laboratory, Shriners Hospitals for Children, Chicago, Illinois, USA.
Chaya N MuraliDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Sandesh C S NagamaniDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Members of the Brittle Bone Disorders Consortium (BBDC)
Peter A SmithMotion Analysis Laboratory, Shriners Hospitals for Children, Chicago, Illinois, USA.
Gerald F HarrisOrthopaedic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Marquette University · USBaylor College of Medicine · USShriners Hospitals for Children - Chicago · US

Funding

Project 3: 3D ImagingU54AR068069 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI Brendan Lee · 2014 to 2026
$19.3M
Brittle Bone Disorders Consortium (BBDC)Eunice Kennedy Shriver National Institutes of Child Health and Development (NICHD) 1U54AR068069HHS/NIDILRR 90ARHF0006-01National Center for Advancing Translational Sciences (NCATS)National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)National Institute of Dental and Craniofacial Research (NIDCR)NIAMS NIH HHS U54 AR068069NIH HHSOffice of Rare Diseases Research (ORDR)OREC at Marquette UniversityShriners Hospitals for Children
6 · The paper itself

Abstract

The objective was to describe pain characteristics and treatments used in individuals with varying severity of osteogenesis imperfecta (OI) and investigate pain-associated variables. This work was derived from a multicenter, longitudinal, observational, natural history study of OI conducted at 12 clinical sites of the NIH Rare Diseases Clinical Research Network's Brittle Bone Disorders Consortium. Children and adults with a clinical, biochemical, or molecular diagnosis of OI were enrolled in the study. We did a cross-sectional analysis of chronic pain prevalence, characteristics, and treatments used for pain relief and longitudinal analysis to find the predictors of chronic pain. We included 861 individuals with OI, in 41.8% chronic pain was present, with similar frequency across OI types. Back pain was the most frequent location. Nonsteroidal anti-inflammatory drugs followed by bisphosphonates were the most common treatment used. Participants with chronic pain missed more days from school or work/year and performed worse in all mobility metrics than participants without chronic pain. The variables more significantly associated with chronic pain were age, sex, positive history of rodding surgery, scoliosis, other medical problems, assistive devices, lower standardized height, and higher body mass index. The predictors of chronic pain for all OI types were age, use of a wheelchair, and the number of fractures/year. Chronic pain is prevalent in OI across all OI types, affects mobility, and interferes with participation. Multiple covariates were associated with chronic pain.

Indexed as

Chronic PainFractures, BoneOsteogenesis ImperfectaAdultChildCross-Sectional StudiesDiphosphonatesHumansDiphosphonatesanalgesiabisphosphonateschronic painosteogenesis imperfecta: Patient team carepain management

Identifiers

PMID36271817
PMCPMC10399129
OpenAlexW4307093832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.